Cargando…
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77
Prostate cancer is the most common cancer occurring in men in the United States. The monoclonal antibody F77 that was originally developed in our laboratory recognizes mainly glycolipids as well as O-linked glycosylation on proteins in prostate cancer cells. We have identified a spliced form of glyc...
Autores principales: | Chen, Xi, Nagai, Yasuhiro, Zhu, Zhiqiang, Ruan, Hang, Peehl, Donna M., Greene, Mark I., Zhang, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790488/ https://www.ncbi.nlm.nih.gov/pubmed/29423071 http://dx.doi.org/10.18632/oncotarget.23341 |
Ejemplares similares
-
Determination of Carbohydrate Structure Recognized by Prostate-specific F77 Monoclonal Antibody through Expression Analysis of Glycosyltransferase Genes
por: Nonaka, Motohiro, et al.
Publicado: (2014) -
Carbohydrate Sequence of the Prostate Cancer-associated Antigen F77 Assigned by a Mucin O-Glycome Designer Array
por: Gao, Chao, et al.
Publicado: (2014) -
CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022) -
Multimerization of Drosophila sperm protein Mst77F causes a unique condensed chromatin structure
por: Kost, Nils, et al.
Publicado: (2015) -
Systematic synthesis of bisected N-glycans and unique recognitions by glycan-binding proteins
por: Cao, Xuefeng, et al.
Publicado: (2022)